How Beth Stavola of MPX Bioceutical is Building a Multi-State Cannabis Operator with Scale

Delving into the Weeds with Beth Stavola of MPX

Guest post by KCSA Strategic Communications

Welcome back to another episode of the Green Rush! This week, Anne, & Lewis chat with fellow New Jerseyan Beth Stavola, the Chief Operating Officer of MPX Bioceutical, one of the leading, vertically integrated holding companies in the cannabis industry. Beth began her cannabis journey in 2012, shortly after Arizona voters approved medical cannabis in the state, and opened one of the first dispensaries along Arizona’s southern border in the town of Douglas. Since then, she’s built a cannabis empire that stretches across the U.S. and was most recently acquired by MPX in January 2017 for $25 million. In this week’s conversation, Beth dives in on a number of topics including the differences in running a public cannabis company in Canada vs. being public in the US, the role of women and minorities in the burgeoning cannabis industry and how she was able to convince her younger sister to follow in her footsteps and into the cannabis industry.

Listen to the interview of Beth Stavola of MPX Bioceutical Corporation,  hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications:

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter